Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | TRHR | P34981 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL7325613 | 1.00 | DPP4 (0.43) | DPP4DPP8DPP9TRHR | |
| Bromide SCHEMBL7325997 | 1.00 | DPP4 (0.43) | DPP4DPP8DPP9TRHR | |
| SCHEMBL1000430 | 0.99 | DPP4 (0.44) | DPP4DPP8DPP9TRHR | |
| SCHEMBL2182026 | 0.99 | DPP4 (0.44) | DPP4DPP8DPP9TRHR | |
| SCHEMBL1000429 | 0.99 | DPP4 (0.44) | DPP4DPP8DPP9TRHR | |
| SCHEMBL10454951 | 0.95 | TRHR (0.43) | DPP4DPP8DPP9TRHR | |
| SCHEMBL10454953 | 0.95 | TRHR (0.43) | DPP4DPP8DPP9TRHR | |
| SCHEMBL5734357 | 0.90 | DPP4 (0.44) | DPP4DPP8DPP9 | |
| SCHEMBL4595209 | 0.90 | DPP4 (0.44) | DPP4DPP8DPP9 | |
| SCHEMBL4595206 | 0.90 | DPP4 (0.44) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0933379-B1 | NOVEL PEPTIDE DERIVATIVES HAVING THIAZOLYL-ALANINE RESIDUE | SHIONOGI & CO (JP) | 2006-03-22 | — | — | EP | disclosed |
| US-6319902-B1 | TO ACTIVATE THE CENTRAL NERVOUS SYSTEM, SUCH AS, FOR EXAMPLE, SUSTAINED ACETYLCHOLINE RELEASING ACTION, ANTI-RESERPINE ACTION AND LOCOMOTOR INCREMENT | SHIONOGI & CO., LTD. (JP) | 2001-11-20 | — | — | US | disclosed |
| EP-0933379-A1 | NOVEL PEPTIDE DERIVATIVES HAVING THIAZOLYL-ALANINE RESIDUE | SHIONOGI & CO., LTD. (JP) | 1999-08-04 | — | — | EP | disclosed |